A 22-year old female has a congenital anemia that required multiple transfusions of red blood cells for many years. She now has no significant findings on physical examination. However, her liver function test results are abnormal. Which of the following findings would most likely appear in a liver biopsy –

**Core Concept**
The underlying condition described is likely a congenital hemolytic anemia, such as beta-thalassemia major, which requires frequent blood transfusions. These transfusions can lead to iron overload due to the breakdown of transfused red blood cells. **Iron overload** is a significant concern in such patients.

**Why the Correct Answer is Right**
The correct answer is related to the effects of iron overload on the liver. Iron accumulation in the liver can lead to **hepatic fibrosis** and potentially **cirrhosis** due to the toxic effects of excess iron on hepatocytes. This condition is known as **hemochromatosis** when it occurs due to genetic causes, but in this context, it's secondary to multiple transfusions.

**Why Each Wrong Option is Incorrect**
**Option A:** Would be incorrect because it does not directly relate to the liver findings in a patient with iron overload due to transfusions.
**Option B:** Is not the most likely finding because, while liver damage can occur, the specific finding related to iron overload is more directly related to iron deposition.
**Option C:** Might seem plausible but does not accurately describe the primary liver biopsy finding in a patient with iron overload due to transfusions.
**Option D:** Is incorrect as it does not specifically address the liver condition resulting from long-term transfusions and iron overload.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that patients receiving frequent blood transfusions are at risk for **iron overload**, which can lead to significant organ damage, including the liver. Monitoring and management of iron levels are crucial in these patients.

**Correct Answer:** D. Hemosiderin deposition.

✓ Correct Answer: D. Hemosiderin in hepatocytes